Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BMEA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BMEA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Biomea Fusion Inc

BMEA
Current price
1.78 USD -0.17 USD (-8.72%)
Last closed 1.94 USD
ISIN US09077A1060
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 110 052 840 USD
Yield for 12 month -68.21 %
1Y
3Y
5Y
10Y
15Y
BMEA
21.11.2021 - 28.11.2021

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California. Address: 1599 Industrial Road, San Carlos, CA, United States, 94070

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.25 USD

P/E Ratio

Dividend Yield

Financials BMEA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BMEA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

+1 220 000 USD

Current Year

Last Year

-4 201 000 USD

Current Quarter

Last Quarter

+1 220 000 USD
EBITDA -130 927 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -74.21 %
PEG Ratio
Return On Equity TTM -156.81 %
Wall Street Target Price 18.25 USD
Revenue TTM
Book Value 0.77 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.54 USD
Diluted Eps TTM -3.54 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation BMEA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.75
Price Book MRQ 3.87

Technical Indicators BMEA

For 52 Weeks

1.29 USD 13.07 USD
50 Day MA 1.91 USD
Shares Short Prior Month 11 962 022
200 Day MA 4.55 USD
Short Ratio 3.01
Shares Short 8 567 781
Short Percent 45.84 %